MedPath

Calcium Acetate

CALCIUM ACETATE Capsules, for Oral Use

Approved
Approval ID

78d66474-09e9-72a8-e053-2991aa0a76ec

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 9, 2024

Manufacturers
FDA

Suven Pharmaceuticals Limited

DUNS: 677604288

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Calcium Acetate Capsules 667 mg

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68022-0119
Application NumberANDA211038
Product Classification
M
Marketing Category
C73584
G
Generic Name
Calcium Acetate Capsules 667 mg
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 9, 2024
FDA Product Classification

INGREDIENTS (3)

CALCIUM ACETATEActive
Quantity: 667 mg in 1 1
Code: Y882YXF34X
Classification: ACTIB
CROSPOVIDONEInactive
Quantity: 10 mg in 1 1
Code: 2S7830E561
Classification: IACT
SODIUM STEARYL FUMARATEInactive
Quantity: 6 mg in 1 1
Code: 7CV7WJK4UI
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Calcium Acetate - FDA Drug Approval Details